• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病性骨质疏松中晚期糖基化终产物(AGEs)的作用。

Role of advanced glycation end products (AGEs) in osteoporosis in diabetes.

机构信息

Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume, Japan.

出版信息

Curr Drug Targets. 2011 Dec;12(14):2096-102. doi: 10.2174/138945011798829456.

DOI:10.2174/138945011798829456
PMID:22023404
Abstract

Recent meta-analyses have revealed that the risk of bone fracture is increased in both type 1 and type 2 diabetic patients. Low bone mineral density (BMD) can not necessarily explain the link, because BMD is increased rather than decreased in type 2 diabetes, while it is consistently low in type 1 diabetes subjects. Although multiple factors could influence the quality of bone and increase the bone fragility in diabetes, there is accumulating evidence for the association between osteoporosis and vascular calcification, which is an independent predictor of cardiovascular disease morbidity and mortality. Advanced glycation end products (AGEs) are formed by a non-enzymatic reaction between aldehydes of reducing sugars and the amino groups of proteins, lipids and nucleic acids that could contribute to the aging of macromolecules. The formation and accumulation of AGEs have been known to progress at an accelerated rate under diabetes. There is a growing body of evidence that AGEs and their receptor (RAGE) system elicit oxidative stress generation and subsequently evoke inflammatory responses in vascular wall cells, osteoblasts and osteoclasts, thereby being involved in both vascular calcification and osteoporosis in diabetes. Further, cross-linking in the organic bone matrix by AGEs could adversely affect the fracture resistance of bone. Therefore, in this paper, I review the pathophysiological role of the AGEs-RAGE-oxidative stress system in decreased BMD and increased bone fragility in diabetes. I also discuss here the potential therapeutic interventions of the AGEs-RAGE axis for preventing osteoporosis in diabetes.

摘要

最近的荟萃分析显示,1 型和 2 型糖尿病患者的骨折风险均增加。骨矿物质密度(BMD)的降低不一定能解释这种关联,因为 2 型糖尿病患者的 BMD 升高而不是降低,而 1 型糖尿病患者的 BMD 则一直较低。尽管有多种因素可能影响骨骼质量并增加糖尿病患者的骨骼脆弱性,但越来越多的证据表明骨质疏松症与血管钙化之间存在关联,血管钙化是心血管疾病发病率和死亡率的独立预测因素。晚期糖基化终产物(AGEs)是由还原糖的醛基与蛋白质、脂质和核酸的氨基之间的非酶反应形成的,这可能导致大分子的衰老。在糖尿病中,AGEs 的形成和积累速度已知会加快。越来越多的证据表明,AGEs 及其受体(RAGE)系统会引发氧化应激的产生,并随后在血管壁细胞、成骨细胞和破骨细胞中引发炎症反应,从而参与糖尿病中的血管钙化和骨质疏松症。此外,AGEs 在有机骨基质中的交联可能会对骨骼的抗断裂能力产生不利影响。因此,在本文中,我回顾了 AGEs-RAGE-氧化应激系统在糖尿病中降低 BMD 和增加骨骼脆弱性的病理生理作用。我还讨论了 AGEs-RAGE 轴在预防糖尿病性骨质疏松症方面的潜在治疗干预措施。

相似文献

1
Role of advanced glycation end products (AGEs) in osteoporosis in diabetes.糖尿病性骨质疏松中晚期糖基化终产物(AGEs)的作用。
Curr Drug Targets. 2011 Dec;12(14):2096-102. doi: 10.2174/138945011798829456.
2
Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes.晚期糖基化终末产物(AGEs)与氧化应激在糖尿病血管并发症中的作用
Biochim Biophys Acta. 2012 May;1820(5):663-71. doi: 10.1016/j.bbagen.2011.03.014. Epub 2011 Apr 2.
3
Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.晚期糖基化终末产物受体内源性可溶性形式(sRAGE)在糖尿病中的动力学、作用及治疗意义
Curr Drug Targets. 2007 Oct;8(10):1138-43. doi: 10.2174/138945007782151298.
4
Advanced glycation end products and insulin resistance.晚期糖基化终末产物与胰岛素抵抗
Curr Pharm Des. 2008;14(10):987-9. doi: 10.2174/138161208784139747.
5
Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients.晚期糖基化终末产物可能参与糖尿病患者骨质疏松症的发病机制。
Med Hypotheses. 2005;65(6):1013-5. doi: 10.1016/j.mehy.2005.07.017.
6
Advanced Glycation End Products, Diabetes, and Bone Strength.晚期糖基化终末产物、糖尿病与骨强度
Curr Osteoporos Rep. 2016 Dec;14(6):320-326. doi: 10.1007/s11914-016-0332-1.
7
Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.晚期糖基化终末产物:糖尿病血管并发症的分子靶点
Mol Med. 2015 Oct 27;21 Suppl 1(Suppl 1):S32-40. doi: 10.2119/molmed.2015.00067.
8
Advanced glycation end products (AGEs) and their involvement in liver disease.晚期糖基化终末产物(AGEs)及其与肝脏疾病的关系。
Curr Pharm Des. 2008;14(10):969-72. doi: 10.2174/138161208784139701.
9
DNA-aptamers raised against AGEs as a blocker of various aging-related disorders.针对晚期糖基化终末产物(AGEs)产生的DNA适配体,作为各种与衰老相关疾病的阻滞剂。
Glycoconj J. 2016 Aug;33(4):683-90. doi: 10.1007/s10719-016-9682-2. Epub 2016 Jun 24.
10
[Non-enzymatic glycation and oxidative stress in chronic illnesses and diabetes mellitus].慢性病与糖尿病中的非酶糖基化和氧化应激
Med Klin (Munich). 1999 Jan 15;94(1):29-38. doi: 10.1007/BF03044692.

引用本文的文献

1
Clinical factors associated with advanced glycation end-products (AGEs) levels evaluated by skin autofluorescence of schoolchildren in Japan.通过日本学童皮肤自发荧光评估的与晚期糖基化终产物(AGEs)水平相关的临床因素。
Clin Pediatr Endocrinol. 2025 Jul;34(3):162-171. doi: 10.1297/cpe.2024-0042. Epub 2025 May 24.
2
Serum uric acid/creatinine ratio and osteoporosis in the elderly: a NHANES study.老年人血清尿酸/肌酐比值与骨质疏松症:一项美国国家健康与营养检查调查研究
Front Med (Lausanne). 2025 Apr 25;12:1530116. doi: 10.3389/fmed.2025.1530116. eCollection 2025.
3
Aptamers as Diagnostic and Therapeutic Agents for Aging and Age-Related Diseases.
适配体作为衰老及衰老相关疾病的诊断和治疗剂
Biosensors (Basel). 2025 Apr 5;15(4):232. doi: 10.3390/bios15040232.
4
Apixaban Inhibits Progression of Experimental Diabetic Nephropathy by Blocking Advanced Glycation End Product-Receptor Axis.阿哌沙班通过阻断晚期糖基化终末产物-受体轴抑制实验性糖尿病肾病的进展。
Int J Mol Sci. 2025 Mar 26;26(7):3007. doi: 10.3390/ijms26073007.
5
Epimedium brevicornum Maxim alleviates diabetes osteoporosis by regulating AGE-RAGE signaling pathway.淫羊藿通过调节AGE-RAGE信号通路减轻糖尿病性骨质疏松症。
Mol Med. 2025 Mar 15;31(1):101. doi: 10.1186/s10020-025-01152-2.
6
Bone Mineral Density is Negatively Associated with Risk of All-Cause and Cardiovascular Mortality among Adults with Type 2 Diabetes Mellitus: A Cross-sectional Study of the NHANES 2005-2010, 2013-2014.骨密度与2型糖尿病成年人全因死亡和心血管死亡风险呈负相关:2005 - 2010年、2013 - 2014年美国国家健康与营养检查调查的横断面研究
Rev Cardiovasc Med. 2024 Dec 11;25(12):434. doi: 10.31083/j.rcm2512434. eCollection 2024 Dec.
7
Vitamin D3 mitigates myopathy and metabolic dysfunction in rats with metabolic syndrome: the potential role of dipeptidyl peptidase-4.维生素D3减轻代谢综合征大鼠的肌病和代谢功能障碍:二肽基肽酶-4的潜在作用
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):3697-3715. doi: 10.1007/s00210-024-03439-3. Epub 2024 Oct 2.
8
The Effects of Dietary Intervention and Macrophage-Activating Factor Supplementation on Cognitive Function in Elderly Users of Outpatient Rehabilitation.膳食干预和巨噬细胞激活因子补充对老年门诊康复患者认知功能的影响。
Nutrients. 2024 Jun 28;16(13):2078. doi: 10.3390/nu16132078.
9
Effect of non-enzymatic glycation on collagen nanoscale mechanisms in diabetic and age-related bone fragility.非酶糖基化对糖尿病及与年龄相关的骨脆性中胶原纳米级机制的影响。
Biocell. 2023 Jun 21;47(7):1651-1659. doi: 10.32604/biocell.2023.028014.
10
Galectin-3 and RAGE differentially control advanced glycation endproduct-induced collagen damage in murine intervertebral disc organ culture.半乳糖凝集素-3和晚期糖基化终末产物受体对小鼠椎间盘器官培养中晚期糖基化终末产物诱导的胶原蛋白损伤具有不同的调控作用。
JOR Spine. 2023 Mar 28;6(2):e1254. doi: 10.1002/jsp2.1254. eCollection 2023 Jun.